Baseline characteristics of the whole cohort
| Characteristic . | All patients (N = 690) . | Missing . | Unclassifiable . |
|---|---|---|---|
| Male sex | 350 (51) | ||
| Median age (range), y | 77.1 (70-96) | ||
| Tumor bulk >10 cm | 136 (20) | 3 | |
| B symptoms at diagnosis | 243 (35) | 4 | |
| IPI score of 3 to 5 | 451 (66) | 8 | |
| Hemoglobin ≤12.5 g/dL at diagnosis | 413 (58) | 1 | |
| Albumin ≤36 g/L at diagnosis | 362 (53) | 1 | |
| CIRS-G score <6 | 371 (54) | 8 | |
| Antibiotic prophylaxis | 119 (17) |
| Characteristic . | All patients (N = 690) . | Missing . | Unclassifiable . |
|---|---|---|---|
| Male sex | 350 (51) | ||
| Median age (range), y | 77.1 (70-96) | ||
| Tumor bulk >10 cm | 136 (20) | 3 | |
| B symptoms at diagnosis | 243 (35) | 4 | |
| IPI score of 3 to 5 | 451 (66) | 8 | |
| Hemoglobin ≤12.5 g/dL at diagnosis | 413 (58) | 1 | |
| Albumin ≤36 g/L at diagnosis | 362 (53) | 1 | |
| CIRS-G score <6 | 371 (54) | 8 | |
| Antibiotic prophylaxis | 119 (17) |
Data are presented as n (%) unless otherwise specified.